Find your next paid study

Christopher D. VerricoNCT07218549

Phase 2

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Background: During a transplant, blood stem cells from one person are given to someone else. The cells grow into the different cells that make up the immune s…

Lymphoproliferative DisordersAutoimmune LymphoproliferativeImmune System Diseases+2 more

National Cancer Institute (NCI)NCT04339777

~$10 – $5,625

Open-label Feasibility Trial of HD-tDCS During Cognitive Behavioral Therapy for Cocaine Use Disorder

Cocaine Use Disorder (CocUD) is a significant public health issue with increasing cocaine-related overdose mortality. Effective treatments for CocUD are highly…

Cocaine Use Disorder

Virginia Commonwealth UniversityNCT07829263

~$10 – $6,250

Phase 3

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder

The purpose of this study is to assess KarXT + KarX-EC for the treatment of irritability associated with autism in children and adolescents.

Irritability Associated With Autism Spectrum Disorder

Bristol-Myers SquibbNCT07285798

Phase 2

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

Background: Allogeneic blood or marrow transplant is when stem cells are taken from one person s blood or bone marrow and given to another person. Researchers…

Primary T-cell Immunodeficiency DisordersCommon Variable ImmunodeficiencyImmune System Diseases+2 more

National Cancer Institute (NCI)NCT02579967

~$10 – $5,625

Bipolar DisorderBipolar and Related DisordersVeterans+3 more

Targeted Alternating Current and Cognitive Training Intervention for Cognitive Control in Bipolar Disorders (TACTIC-BD)

This study is testing whether a type of gentle brain stimulation, combined with computer-based brain training exercises, can help improve thinking skills in Ve…

VA Office of Research and DevelopmentNCT07845409

~$10 – $5,625

Phase 1

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder - Part II

This phase I trial studies the safety and side effects of low-dose sirolimus in treating patients with RUNX1 familial platelet disorder (FPD). RUNX1-FPD is a r…

Familial Platelet Disorder With Associated Myeloid Malignancy

OHSU Knight Cancer InstituteNCT07844694

Alcohol Use DisorderAlcohol AbuseSubstance Use Disorders+1 more

Study of Transcutaneous Auricular Neurostimulation as a Treatment for Substance Use Disorder

The study will involve a 5-day tAN treatment to attenuate alcohol withdrawal syndrome (AWS) and alter resting state functional connectivity (RSFC) between OFC …

Spark Biomedical, Inc.NCT07281261

~$10 – $8,750

Investigating the Mechanistic Biology of Primary Immunodeficiency Disorders

Background: Primary immunodeficiency disorders, or PIDs, are diseases that weaken the immune system. This makes it easier for a person to get sick. Some PIDs …

Primary Immunodeficiency Disorders

National Institute of Allergy and Infectious Diseases (NIAID)NCT03394053

~$10 – $675

Opioid Use DisorderPoor Quality Sleep

Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for Opioid Use Disorder

This study is to develop and test a medical health application based on cognitive behavioral therapy for insomnia and augmented with other evidence-based sleep…

Medical University of South CarolinaNCT06157840

~$10 – $6,250

Feasibility Study to Evaluate the Initial Safety and Effectiveness of TRUFILL n-BCA Liquid Embolic System in Middle Meningeal Artery Embolization for the Preventive Treatment of Refractory Chronic Migraine

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle menin…

Migraine Disorders

Cerenovus, Part of DePuy Synthes Products, Inc.NCT06735833

~$10 – $8,750

Oral Potentially Malignant LesionsOral Potentially Malignant DisordersOral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer+1 more

Feasibility and Validation of an Automated AI-Enabled Deep Ultraviolet (DUV) Cytology Platform for Point-of-Care Oral Cancer Triage

This research study evaluates an experimental, point-of-care tool that combines Deep Ultraviolet (DUV) light imaging with Artificial Intelligence (AI) to rapid…